Bushen Huoxue decoction improves cognitive decline in rats with cerebral hypoperfusion

Molecular Medicine Reports

Volumn 10, Issue 3, 2014, Pages 1635-1641

  Ye, Shuifen ^a   Gu, Yong ^b   Xu, Yihui ^a   Fan, Wen ^a   Wang, Xiaoting ^a   Chen, Shuting ^a   Cai, Siyi ^a   Lv, Shirong ^a   Tong, Yao ^b   Cai, Jing ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b THE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Antioxidant enzymes; Bushen Huoxue decoction; Synapse density; Vascular dementia

Indexed keywords

BUSHEN HUOXUE DECOCTION; CATALASE; GINKGO BILOBA EXTRACT; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; HERBACEOUS AGENT; MALONALDEHYDE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; ANTIOXIDANT; BUSHEN HUOXUE; GLUTATHIONE PEROXIDASE; NEUROPROTECTIVE AGENT; PLANT MEDICINAL PRODUCT;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CORTEX; BRAIN HOMOGENATE; BRAIN PERFUSION; CAROTID ARTERY OBSTRUCTION; CHINESE HERB; COGNITIVE DEFECT; COMMON CAROTID ARTERY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIMEDIUM; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; LEARNING DISORDER; MORRIS WATER MAZE TEST; MULTIINFARCT DEMENTIA; NONHUMAN; PARIETAL CORTEX; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RAT; SALVIA MILTIORRHIZA; SPATIAL LEARNING; SPATIAL MEMORY; SYNAPSE; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING; ANIMAL; BRAIN ISCHEMIA; COGNITION; DRUG EFFECTS; HIPPOCAMPUS; LEARNING; MAZE TEST; MEMORY DISORDERS; METABOLISM; PHYTOTHERAPY; WISTAR RAT;

ANIMALS; ANTIOXIDANTS; BRAIN ISCHEMIA; CATALASE; CEREBRAL CORTEX; COGNITION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; GLUTATHIONE PEROXIDASE; HIPPOCAMPUS; LEARNING; MALONDIALDEHYDE; MAZE LEARNING; MEMORY DISORDERS; MICROSCOPY, ELECTRON, TRANSMISSION; NEUROPROTECTIVE AGENTS; PHYTOTHERAPY; PLANT PREPARATIONS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 84905441448     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2355     Document Type: Article

References (36)

1. Gorelick PB and Pantoni L: Advances in vascular cognitive impairment. Stroke 44: 307-308, 2013.
2. Chui HC: Vascular cognitive impairment: today and tomorrow. Alzheimers Dement 2: 185-194, 2006.
3. Moorhouse P and Rockwood K: Vascular cognitive impairment: current concepts and clinical developments. Lancet Neurol 7: 246-255, 2008. (Pubitemid 351215983)
4. Consoli A, Pasi M and Pantoni L: Vascular mild cognitive impairment: concept, definition, and directions for future studies. Aging Clin Exp Res 24: 113-116, 2012.
5. Dichgans M and Zietemann V: Prevention of vascular cognitive impairment. Stroke 43: 3137-3146, 2012.
6. Kalaria RN: Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans. Stroke 43: 2526-2534, 2012.
7. Luckhaus C, Flüb MO, Wittsack HJ, et al: Detection of changed regional cerebral blood flow in mild cognitive impairment and early Alzheimer's dementia by perfusion-weighted magnetic resonance imaging. Neuroimage 40: 495-503, 2008.
8. Panza F, Frisardi V, Capurso C, et al: Metabolic syndrome and cognitive impairment: current epidemiology and possible underlying mechanisms. J Alzheimers Dis 21: 691-724, 2010.
9. Clare R, King VG, Wirenfeldt M and Vinters HV: Synapse loss in dementias. J Neurosci Res 88: 2083-2090, 2010.
10. Jesky R and Hailong C: Are herbal compounds the next frontier for alleviating learning and memory impairments? An integrative look at memory, dementia and the promising therapeutics of traditional chinese medicines. Phytother Res 25: 1105-1118, 2011.
11. Liu X, Du J, Cai J, Xu G, Lin A and Teng Q: Clinical systematic observation of Kangxin capsule curing vascular dementia of senile kidney deficiency and blood stagnation type. J Ethnopharmacol 112: 350-355, 2007. (Pubitemid 46756081)
12. Moss G: The adequacy of the cerebral collateral circulation: tolerance of awake experimental animals to acute bilateral common carotid artery occlusion. J Surg Res 16: 337-338, 1974.
13. Brondino N, De Silvestri A, Re S, et al: A Systematic review and meta-analysis of ginkgo biloba in neuropsychiatric disorders: from ancient tradition to modern-day medicine. Evid Based Complement Alternat Med 2013: 915691, 2013.
14. Ihl R: Effects of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: review of recently completed randomised, controlled trials. Int J Psychiatry Clin Pract 1 (Suppl 1): 8-14, 2013.
15. Morris R: Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60, 1984.
16. Feng Z, Lu Y, Wu X, et al: Ligustilide alleviates brain damage and improves cognitive function in rats of chronic cerebral hypoperfusion. J Ethnopharmacol 144: 313-321, 2012.
17. Scheff SW, Price DA, Schmitt FA, et al: Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68: 1501-1508, 2007. (Pubitemid 46685921)
18. Wang X, Xing A, Xu C, Cai Q, Liu H and Li L: Cerebrovascular hypoperfusion induces spatial memory impairment, synaptic changes, and amyloid-β oligomerization in rats. J Alzheimers Dis 21: 813-822, 2010.
19. O'Brien JT, Erkinjuntti T, Reisberg B, et al: Vascular cognitive impairment. Lancet Neurol 2: 89-98, 2003. (Pubitemid 37443329)
20. Ramos-Estébanez C, Moral-Arce I, Muñoz-Arrondo R, et al: Vascular cognitive impairment: prodromal stages of ischemic vascular dementia. Dement Geriatr Cogn Disord 25: 451-460, 2008. (Pubitemid 351630079)
21. Hachinski V, Iadecola C, Petersen RC, et al: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 37: 2220-2241, 2006. (Pubitemid 44337162)
22. Bowler JV: Modern concept of vascular cognitive impairment. Br Med Bull 83: 291-305, 2007.
23. D'Hooge R and De Deyn PP: Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev 36: 60-90, 2001. (Pubitemid 32763130)
24. Dong H, Martin MV, Chambers S and Csernansky JG: Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice. J Comp Neurol 500: 311-321, 2007. (Pubitemid 44937125)
25. Marcello E, Epis R, Saraceno C and Di Luca M: Synaptic dysfunction in Alzheimer's disease. Adv Exp Med Biol 970: 573-601, 2012.
26. Yao ZB, Li X and Xu ZC: GABAergic and asymmetrical synapses on somata of GABAergic neurons in CA1 and CA3 regions of rat hippocampus. A quantitative electron microscopic analysis. Stroke 27: 1411-1415, 1996.
27. Hai J, Yu F, Lin Q and Su SH: The changes of signal transduction pathways in hippocampal regions and postsynaptic densities after chronic cerebral hypoperfusion in rats. Brain Res 1429: 9-17, 2012.
28. Berr C, Balansard B, Arnaud J, Roussel AM and Alperovitch A: Cognitive decline is associated with systemic oxidative stress: the EVA study. Etude du Vieillissement Artériel. J Am Geriatr Soc 48: 1285-1291, 2000.
29. Reiter RJ: Oxidative processes and antioxidative defense mechanisms in the aging brain. FASEB J 9: 526-533, 1995.
30. Mecocci P, Mariani E, Cornacchiola V and Polidori MC: Antioxidants for the treatment of mild cognitive impairment. Neurol Res 26: 598-602, 2004. (Pubitemid 38879246)
31. Bennett S, Grant MM and Aldred S: Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology. J Alzheimers Dis 17: 245-257, 2009.
32. López N, Tormo C, De Blas I, Llinares I and Alom J: Oxidative stress in Alzheimer's disease and mild cognitive impairment with high sensitivity and specificity. J Alzheimers Dis 33: 823-829, 2013.
33. Yuan D, Wang H, He H, et al: Protective effects of total flavonoids from Epimedium on the male mouse reproductive system against cyclophosphamide-induced oxidative injury by up-regulating the expressions of SOD3 and GPX1. Phytother Res 28: 88-97, 2014.
34. Cheng H, Feng S, Jia X, Li Q, Zhou Y and Ding C: Structural characterization and antioxidant activities of polysaccharides extracted from Epimedium acuminatum. Carbohydr Polym 92: 63-68, 2013.
35. Wu YC and Hsieh CL: Pharmacological effects of Radix Angelica Sinensis (Danggui) on cerebral infarction. Chin Med 6: 32, 2011.
36. Mansour SM, Bahgat AK, El-Khatib AS and Khayyal MT: Ginkgo biloba extract (EGb 761) normalizes hypertension in 2K, 1C hypertensive rats: role of antioxidant mechanisms, ACE inhibiting activity and improvement of endothelial dysfunction. Phytomedicine 18: 641-647, 2011.